China’s new pharmaceutical patent term compensation system
China has recently implemented significant amendments to its patent law effective January 20, 2024, including the introduction of a novel pharmaceutical patent term compensation system. This reform is especially pertinent to the pharmaceutical industry and comes subsequent to the adoption of the 2023 Detailed Rules for the Implementation of the Patent Law and the Guidelines for Patent Examination under the updated Chinese Patent Law. These alterations, impacting various stakeholders within the sector, bring forth a more nuanced approach to patent [...]
